RARITAN, N.J., May 3, 2021 /CNW/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ORTHO ...
ORTHO Sera ID-MTS Antigen Phenotyping Cleared on ORTHO VISION® Platforms in United States and Canada
RARITAN, N.J., March 10, 2020 /PRNewswire-PRWeb/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, ...
FDA-approved MTS™ DAT Card and advanced ORTHO VISION™ Platform highlight the company's continued leadership in transfusion medicine SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- QuidelOrtho Corporation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results